Delft is part of a consortium which, with EDCTP funding, is trying to measure the impact of a TB/HIV household intervention by doing a prevalence survey. (for more info visit Treats Project website https://treatsproject.org ). [...]
From 27-30 January 2020 you can find us at the Arab Health Conference in Dubai. At our booth #2.A30 we can tell you all about our Diagnostic Centres and CAD4TB and RetCAD software.
Will we see you there?
The TREATS Tuberculosis (TB) Prevalence Survey commenced in South Africa with a pilot in Wellington from 4-8 March 2019. The intensive diagnostic phase (IDP) subsequently started in Luvuyo site in Khayelitsha township on 25 March 2019.
This study demonstrates that CAD4TB was better than human readers in detecting bacteriologically confirmed TB. Furthermore, the study showed that the latest version of CAD4TB showed improved performance.
Researchers have concluded that results from the HPTN071 (PopART) trial provide evidence of a 20 percent reduction in HIV incidence when communities are proactively offered HIV testing and linkages to treatment and prevention.